Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. April 2019 09:10 ET | Quelle: Kali, Inc.

Kali-Extracts Hemp4mula CBD Infused Gum For Sale On USMJ.com Next Week

DALLAS, April 11, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) is a health and wellness company set to generate revenue...
09. April 2019 15:25 ET | Quelle: Kali, Inc.

Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th

DALLAS, April 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an online presentation scheduled next...
09. April 2019 09:00 ET | Quelle: Kali, Inc.

Kali-Extracts Announces Cannabis Treatment For $9 Billion Epilepsy Market Under Development

DALLAS, April 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a treatment for epilepsy derived from...
05. April 2019 14:13 ET | Quelle: Kali, Inc.

Kali-Extracts Confirms 4th Cannabis Extract Pharmaceutical Research Project Adding To Research Targeting $160 Million Market

DALLAS, April 05, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed plans to reveal a fourth research and...
04. April 2019 10:15 ET | Quelle: Kali, Inc.

Kali-Extracts Announces Developing Cannabis Pain Management Treatment For $83 Billion Market Specifically Targeting Cancer

DALLAS, April 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its ongoing research and development of...
02. April 2019 09:40 ET | Quelle: Kali, Inc.

KALY - Kali-Extracts Develops Cannabis Treatment For Type 2 Diabetes Expected To Be $64 Billion Market

DALLAS, April 02, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today unveiled its ongoing research and development of a...
29. März 2019 10:48 ET | Quelle: Kali, Inc.

KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market

DALLAS, March 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced finalizing it’s all new 25 mg CBD...
26. März 2019 13:51 ET | Quelle: Kali, Inc.

KALY Announces A New Step Forward For Its Cannabis Extraction Lab

DALLAS, March 26, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that the State of Texas plans to remove...
21. März 2019 13:18 ET | Quelle: Kali, Inc.

KALY Confirms Pharmaceutical Cannabis Extract Report On Recent Trials Scheduled For Tomorrow

DALLAS, March 21, 2019 (GLOBE NEWSWIRE) -- -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company plans to publish its...
20. März 2019 13:45 ET | Quelle: Kali, Inc.

KALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019

DALLAS, March 20, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company plans to publish its phase...

Vorherige Seite

Nächste Seite